Literature DB >> 26595305

Differences of microbiota in small bowel and faeces between irritable bowel syndrome patients and healthy subjects.

Chen-Shuan Chung1,2,3, Pi-Feng Chang4,5, Chun-Hsing Liao6, Tzong-Hsi Lee1, Yun Chen7, Yi-Chia Lee8, Ming-Shiang Wu8, Hsiu-Po Wang8, Yen-Hsuan Ni9.   

Abstract

OBJECTIVE: Several studies suggested that colonic microbiota have impacts on irritable bowel syndrome (IBS) patients. However, the knowledge about the association of small intestine (SI) microbiota with IBS is limited. We aimed to investigate the gut microbiota composition of SI and stool in IBS patients.
MATERIALS AND METHODS: Biopsies of jejunum mucosa by balloon-assisted enteroscopy and faecal samples from 28 IBS patients and 19 healthy controls were analysed by next-generation sequencing method.
RESULTS: The three major phyla in SI microbiota of case/control groups were Proteobacteria (32.8/47.7%), Bacteroidetes (25.2/15.3%), and Firmicutes (19.8/11.2%), and those of stool were Bacteroidetes (41.3/45.8%), Firmicutes (40.7/38.2%), and Proteobacteria (15.4/7.1%). Analysis based on the family level, IBS patients had a higher proportion of Veillonellaceae (mean proportion 6.49% versus 2.68%, p = 0.046) in stool than controls. Prevotellaceae was more abundant in IBS patients than in control group (14.27% versus 6.13%, p = 0.023), while Mycobacteriaceae (0.06% versus 0.17%, p = 0.024) and Neisseriaceae (6.40% versus 8.94%, p = 0.038) was less abundant in IBS patients' jejunal mucosa than those in controls. This less abundant jejunal Neisseriaceae was associated with more severe IBS (p = 0.03). The ratio of Firmicutes to Bacteroidetes in the stool of IBS-diarrhoea type patients was approximately three-fold higher, and the ratio of Firmicutes to Actinobacter in SI of IBS-mixed type patients was about nine-fold higher than healthy subjects.
CONCLUSION: Higher abundance of colonic Veillonellaceae and SI Prevotellaceae, and lower amount of oral cavity normal flora in proximal SI were found in IBS patients. We may manipulate these bacteria in IBS patients in future studies (ClinicalTrial.gov Number NCT01679730).

Entities:  

Keywords:  Enteroscopy; irritable bowel syndrome; microbiota; next-generation sequencing; small bowel

Mesh:

Year:  2015        PMID: 26595305     DOI: 10.3109/00365521.2015.1116107

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  26 in total

1.  Comparison of gut microbiota profile in celiac disease, non-celiac gluten sensitivity and irritable bowel syndrome: A systematic review.

Authors:  Elin Lund Transeth; Hanna Fjeldheim Dale; Gülen Arslan Lied
Journal:  Turk J Gastroenterol       Date:  2020-11       Impact factor: 1.852

2.  Hypoxia-induced intestinal barrier changes in balloon-assisted enteroscopy.

Authors:  Tsung-Chun Lee; Yi-Chen Huang; Yen-Zhen Lu; Yu-Chang Yeh; Linda Chia-Hui Yu
Journal:  J Physiol       Date:  2018-01-01       Impact factor: 5.182

3.  Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.

Authors:  Floris Imhann; Arnau Vich Vila; Marc Jan Bonder; Jingyuan Fu; Dirk Gevers; Marijn C Visschedijk; Lieke M Spekhorst; Rudi Alberts; Lude Franke; Hendrik M van Dullemen; Rinze W F Ter Steege; Curtis Huttenhower; Gerard Dijkstra; Ramnik J Xavier; Eleonora A M Festen; Cisca Wijmenga; Alexandra Zhernakova; Rinse K Weersma
Journal:  Gut       Date:  2016-10-08       Impact factor: 23.059

4.  Metagenomic Sequencing of the Gallbladder Microbiome: Bacterial Diversity Does Not Vary by Surgical Pathology.

Authors:  Jessica Limberg; Caitlin E Egan; Hector A Mora; Gregory Putzel; Alexia T Stamatiou; Timothy M Ullmann; Maureen D Moore; Dessislava Stefanova; Jessica W Thiesmeyer; Brendan M Finnerty; Toni Beninato; Katherine McKenzie; R Jonathan Robitsek; Jeffrey Chan; Rasa Zarnegar; Thomas J Fahey
Journal:  J Gastrointest Surg       Date:  2022-08-01       Impact factor: 3.267

Review 5.  The gut-liver axis in sepsis: interaction mechanisms and therapeutic potential.

Authors:  Xue Zhang; Hong Liu; Kenji Hashimoto; Shiying Yuan; Jiancheng Zhang
Journal:  Crit Care       Date:  2022-07-13       Impact factor: 19.334

6.  A Novel Role of SLC26A3 in the Maintenance of Intestinal Epithelial Barrier Integrity.

Authors:  Anoop Kumar; Shubha Priyamvada; Yong Ge; Dulari Jayawardena; Megha Singhal; Arivarasu N Anbazhagan; Ishita Chatterjee; Aneal Dayal; Mitul Patel; Kimia Zadeh; Seema Saksena; Waddah A Alrefai; Ravinder K Gill; Mojgan Zadeh; Ni Zhao; Mansour Mohamadzadeh; Pradeep K Dudeja
Journal:  Gastroenterology       Date:  2020-11-13       Impact factor: 22.682

Review 7.  Mind-Body Interventions for Pediatric Inflammatory Bowel Disease.

Authors:  Ann Ming Yeh; Anava Wren; Brenda Golianu
Journal:  Children (Basel)       Date:  2017-04-03

8.  Leveraging 16S rRNA Microbiome Sequencing Data to Identify Bacterial Signatures for Irritable Bowel Syndrome.

Authors:  Yuxia Liu; Wenhui Li; Hongxia Yang; Xiaoying Zhang; Wenxiu Wang; Sitong Jia; Beibei Xiang; Yi Wang; Lin Miao; Han Zhang; Lin Wang; Yujing Wang; Jixiang Song; Yingjie Sun; Lijuan Chai; Xiaoxuan Tian
Journal:  Front Cell Infect Microbiol       Date:  2021-06-11       Impact factor: 5.293

9.  Dual expression of transgenic delta-5 and delta-6 desaturase in tilapia alters gut microbiota and enhances resistance to Vibrio vulnificus infection.

Authors:  Keng-Yu Chiang; Wen-Chun Lin; Tsung-Yu Tsai; Cheng-Wei Lin; Shin-Jie Huang; Ching-Yu Huang; Sheng-Han Wu; Chuian-Fu Ken; Hong-Yi Gong; Jyh-Yih Chen; Jen-Leih Wu
Journal:  PLoS One       Date:  2020-07-30       Impact factor: 3.240

Review 10.  Role of Gut Microbiota-Gut Hormone Axis in the Pathophysiology of Functional Gastrointestinal Disorders.

Authors:  Hirokazu Fukui; Xin Xu; Hiroto Miwa
Journal:  J Neurogastroenterol Motil       Date:  2018-07-30       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.